Eli Lilly is progressing its experimental obesity and type 2 diabetes drug retatrutide into Phase 3 trials, following late-stage data showing significant weight loss and metabolic improvements.
Retatrutide belongs to…
26

Be the first to know the latest updates
[yikes-mailchimp form="1"]